project id: TCGA-LUSC; case submitter id: TCGA-43-A56V; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; age at index: 61; days to birth: -22475; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1951; age at diagnosis: 22475; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 366.0; icd 10 code: C34.2; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Middle lobe, lung; synchronous malignancy: Yes; tissue or organ of origin: Middle lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; cigarettes per day: 2.6301369863013697; pack years smoked: 48.0; years smoked: 32.0; is ffpe: false; composition: Not Reported; days to collection: 27; days to sample procurement: 0; initial weight: 280.0; portion submitter id: TCGA-43-A56V-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 5.0; percent necrosis: 3.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 67.0; percent tumor nuclei: 80.0;